Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
biotech
clinical trials
eli lilly
3
×
fda
life sciences
national blog main
national top stories
allergan
boston blog main
boston top stories
europe blog main
merck
national
new york blog main
4d molecular therapeutics
acne
agenus
alkermes
amgen
astrazeneca
auris health
avexis
bayer
biohaven
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
buprenorphine
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
cariprazine
celgene
centers for medicare and medicaid services
cgpr
What
fda
3
×
treatment
3
×
approved
drug
adults
alkermes
allergan
antipsychotic
benefits
bio
caveats
class
commonly
companies
designed
digital
disease
effect
epidemic
fatty
favor
frenzied
gain
growing
known
led
liver
medicine
medicines
merck
migraine
monday
nash
new
news
nod
offer
panel
pill
prescribed
Language
unset
Current search:
fda
×
treatment
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More